1. Home
  2. FCAP vs CNXU Comparison

FCAP vs CNXU Comparison

Compare FCAP & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Capital Inc.

FCAP

First Capital Inc.

HOLD

Current Price

$64.80

Market Cap

220.1M

Sector

Finance

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$9.08

Market Cap

208.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCAP
CNXU
Founded
1891
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.1M
208.4M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
FCAP
CNXU
Price
$64.80
$9.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.5K
133.4K
Earning Date
04-24-2026
N/A
Dividend Yield
2.32%
N/A
EPS Growth
36.97
N/A
EPS
1.30
N/A
Revenue
$7,170,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$50.95
N/A
Revenue Growth
1.57
N/A
52 Week Low
$33.88
$7.10
52 Week High
$71.00
$13.66

Technical Indicators

Market Signals
Indicator
FCAP
CNXU
Relative Strength Index (RSI) N/A 35.13
Support Level N/A $7.10
Resistance Level N/A $11.51
Average True Range (ATR) 0.00 1.01
MACD 0.00 -0.10
Stochastic Oscillator 0.00 7.06

Price Performance

Historical Comparison
FCAP
CNXU

About FCAP First Capital Inc.

First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: